
Will the vaccine cure India's economy?
Leading economists believe the vaccine might not end the economic disruption which the Covid-19 pandemic has caused. Normalcy will come over time, and with pain.
Leading economists believe the vaccine might not end the economic disruption which the Covid-19 pandemic has caused. Normalcy will come over time, and with pain.
The latest repo rate cut marks 128 policy rate actions from the Reserve Bank of India, since April 2001; the repo and reverse repo rate have been tweaked 61 and 55 times each since then.
The Narendra Modi government, which is nearing the first full year of its second term, finds itself facing the toughest tightrope walk: the balance between lives and livelihood.
Round II of RBI’s Covid-19 crisis measures was received by the Sensex and the Nifty 50 gaining 1,116 and 331 points each before closing 986 and 273 points higher from the previous day’s close.
Coronavirus could be a catalyst for resetting the agenda of India’s financial market reforms, says Mark Matthews, head of research-Asia, Julius Baer.
Both the benchmark indices closed flat after huge rallies in three consecutive days; they ended the week with over 20% gains from the week’s lows.
Notwithstanding headline inflation being at a five-year high of 7.4%, Nomura expects the RBI to extend its pause; but the next policy move is still likely to be a rate cut in Q2 to boost growth.
Net equity investments of mutual funds fell over 55%, while their investments in debt rose over 59% compared to 2018.
The central bank bought long-term bonds worth ₹10,000 crore and simultaneously sold short-term papers worth ₹6,825 crore under a special OMO to address liquidity issues.
The central bank, according to the policy statement, intends to continue with an accommodative stance as long as it is necessary to revive growth, while ensuring inflation remains within target.